Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 12-2017 | 06-2017 | 12-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,243 | 1,877 | 929 | 1,046 | 1,215 |
| Other current assets | 183 | 65 | 13 | 0 | 45 |
| TOTAL | $1,426 | $1,946 | $942 | $1,047 | $1,264 |
| Non-Current Assets | |||||
| PPE Net | 194 | 192 | N/A | N/A | N/A |
| Intangibles | 263 | 258 | N/A | N/A | N/A |
| TOTAL | $457 | $449 | $0 | $0 | $0 |
| Total Assets | $1,884 | $2,396 | $942 | $1,047 | $1,264 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 283 | 7 | 218 | 144 | 95 |
| TOTAL | $283 | $264 | $218 | $144 | $95 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13 | 0 | 0 | 0 | 0 |
| TOTAL | $13 | $0 | $0 | $0 | $0 |
| Total Liabilities | $296 | $264 | $218 | $144 | $95 |
| Shareholders' Equity | |||||
| Common Shares | 3,602 | 3,601 | 669 | 669 | 649 |
| Retained earnings | -3,654 | -3,007 | -786 | -607 | -262 |
| Other shareholders' equity | -5,700 | -5,803 | 0 | 0 | 0 |
| TOTAL | $1,588 | $2,132 | $724 | $904 | $1,169 |
| Total Liabilities And Equity | $1,884 | $2,396 | $942 | $1,047 | $1,264 |